LEXINGTON, Mass., Sept. 30,
2019 /PRNewswire/ -- Agenus Inc. (NASDAQ: AGEN),
an immuno-oncology (I-O) company with
a pipeline of immune checkpoint antibodies,
adoptive cell therapies1 and cancer vaccines,
announced today that Jennifer Buell,
PhD, Chief Operating Officer of Agenus, present an update on
Agenus' progress and host one-on-one meetings with investors at the
2019 Cantor Global Healthcare Conference on October 4th, 2019 at the InterContinental New
York Barclay Hotel.
The presentation will be webcast live and may be accessed by
visiting the "Events & Presentations" page within the Investors
section of the Agenus website www.agenusbio.com or by using
the link below. A replay of the webcast will be available on the
Agenus website following the conference.
Date: Friday, October 4, 2019
Time: 8:20 A.M. ET
Webcast: http://wsw.com/webcast/cantor10/agen/
About Agenus
Agenus is a clinical-stage immuno-oncology company focused on
the discovery and development of therapies that engage the body's
immune system to fight cancer. The Company's vision is to expand
the patient populations benefiting from cancer immunotherapy with
combination approaches that leverage a broad repertoire of antibody
therapeutics, adoptive cell therapies (through its AgenTus
Therapeutics subsidiary) and its proprietary cancer vaccine
platforms. Agenus has a suite of antibody discovery platforms and a
state-of-the-art GMP manufacturing facility with the capacity to
support early phase clinical programs. Agenus is headquartered in
Lexington, MA. For more
information, please visit www.agenusbio.com and our twitter handle
@agenus_bio. Information that may be important to investors will be
routinely posted on our website and twitter.
Contact:
Agenus Inc.
Jennifer S. Buell, PhD
781-674-4420 jennifer.buell@agenusbio.com
1Through AgenTus Therapeutics,
a subsidiary of Agenus
View original content to download
multimedia:http://www.prnewswire.com/news-releases/agenus-to-present-at-the-2019-cantor-global-healthcare-conference-on-october-4-2019-300928055.html
SOURCE Agenus